deltatrials
Completed PHASE2 INTERVENTIONAL 1-arm NCT05653856

Cu-64-PSMA-I&T Positron Emission Tomography (PET) Imaging of Metastatic PSMA Positive Lesions in Men With Prostate Cancer

A Multi-Center, Open-Label, Randomized Phase 2 Study of Copper Cu 64 PSMA I&T Injection in Patients With Histologically Proven Metastatic Prostate Cancer

Sponsor: Curium US LLC

Conditions Metastasis From Malignant Tumor of Prostate (Disorder)
Interventions 64Cu-PSMA I&T
Updated 8 times since 2023 Last updated: Jan 23, 2025 Started: Dec 5, 2022 Primary completion: May 17, 2023 Completion: May 17, 2023
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT05653856, this PHASE2 trial focuses on Metastasis From Malignant Tumor of Prostate (Disorder) and remains completed. Sponsored by Curium US LLC, it has been updated 8 times since 2022, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2023 – ~Feb 2023 · 31 days · monthly snapshotNot Yet Recruiting~Feb 2023 – ~Apr 2023 · 59 days · monthly snapshotRecruiting~Apr 2023 – ~Sep 2023 · 5 months · monthly snapshotRecruiting~Sep 2023 – ~Jul 2024 · 10 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – ~Feb 2025 · 5 months · monthly snapshotCompleted~Feb 2025 – ~Sep 2025 · 7 months · monthly snapshotCompleted~Sep 2025 – present · 10 months · monthly snapshotCompleted

Change History

8 versions recorded

  1. Sep 2025 — Present [monthly]

    Completed PHASE2

  2. Feb 2025 — Sep 2025 [monthly]

    Completed PHASE2

  3. Sep 2024 — Feb 2025 [monthly]

    Completed PHASE2

  4. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  5. Sep 2023 — Jul 2024 [monthly]

    Completed PHASE2

    Status: Recruiting → Completed

▶ Show 3 earlier versions

  1. Apr 2023 — Sep 2023 [monthly]

    Recruiting PHASE2

  2. Feb 2023 — Apr 2023 [monthly]

    Recruiting PHASE2

    Status: Not Yet Recruiting → Recruiting

  3. Jan 2023 — Feb 2023 [monthly]

    Not Yet Recruiting PHASE2

    First recorded

Dec 2022

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Curium US LLC
Data source: Curium US LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations